Application of nicotinamide adenine dinucleotide in preparation of drug for preventing and treating heart ischemic injuries

A technology of nicotinamide adenine and dinucleotide, which is applied in the fields of drug combination, cardiovascular system diseases, and pharmaceutical formulations, and can solve problems such as the application report of nicotinamide adenine dinucleotide that has not yet been reported.

Inactive Publication Date: 2015-12-23
SHANGHAI CHEST HOSPITAL
View PDF3 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

There is no report on the application of nicotinamide adenine dinucleotide in the

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of nicotinamide adenine dinucleotide in preparation of drug for preventing and treating heart ischemic injuries
  • Application of nicotinamide adenine dinucleotide in preparation of drug for preventing and treating heart ischemic injuries
  • Application of nicotinamide adenine dinucleotide in preparation of drug for preventing and treating heart ischemic injuries

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0012] The experimental content of the present invention on the application of nicotinamide adenine dinucleotide in the preparation of drugs for preventing myocardial ischemia injury mainly includes the following aspects:

[0013] 1. NAD+ has a protective effect on myocardial infarction caused by cardiac ischemia, can reduce infarct volume and lower the level of plasma troponin I.

[0014] 2. NAD+ has a protective effect on apoptosis caused by cardiac ischemia.

[0015] The following pharmacodynamic experiments further illustrate that NAD+ has an obvious therapeutic effect on myocardial ischemia injury caused by myocardial infarction.

[0016] 1. Experimental method

[0017] 1. Animal manipulation

[0018] Rats were used in the research, and the experimental animals were kept in the MED-X Research Institute of Shanghai Jiaotong University for animal experiments. All operating procedures are in compliance with the Shanghai Jiaotong University Laboratory Animal Protection and...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to application of nicotinamide adenine dinucleotide as an active ingredient in preparation of a drug for preventing or treating heart ischemic injuries. In experiments, caudal vein normal saline injection and a heart ischemia operation are carried out on rats in a control group, it is found through research results that a great number of apoptosis signals (TUNEL positive signals) appear on the hearts, while apoptosis signals of rats, on which caudal vein NAD+solution injection is carried out, in an experiment group can be effectively reduced.

Description

technical field [0001] The invention relates to the application of nicotinamide adenine dinucleotide in the field of pharmacy. More specifically, nicotinamide adenine dinucleotide (NAD for short) + ) in the preparation of drugs for the prevention or treatment of cardiac ischemic injury. Background technique [0002] The chemical structural formula of nicotinamide adenine dinucleotide is: [0003] . [0004] The preparation method of nicotinamide adenine dinucleotide mainly uses yeast as raw material, the yeast is extracted by boiling water, the crude product is acidified and precipitated with lead acetate, and the crude product is processed and refined by formic acid type cation exchange resin column. There is no report on the application of nicotinamide adenine dinucleotide in the preparation of drugs for the prevention and treatment of cardiac ischemic injury. Contents of the invention [0005] The object of the present invention is to propose the application of ni...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/7076A61P9/10
Inventor 曲新凯殷卫海张佑俊
Owner SHANGHAI CHEST HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap